America September 15, 2025
Novartis, Monte Rosa $5.7B Deal Targets Immune Diseases
In a bold wager on next-generation drug discovery, Novartis, Monte Rosa $5.7B Deal is set to reshape the landscape of…
America September 15, 2025
In a bold wager on next-generation drug discovery, Novartis, Monte Rosa $5.7B Deal is set to reshape the landscape of…
By Rihem Akkouche